6LLX
Discovery of A Dual Inhibitor of NQO1 and GSTP1 for Treating Malignant Glioblastoma
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRF BEAMLINE BL17U |
| Synchrotron site | SSRF |
| Beamline | BL17U |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-11-03 |
| Detector | DECTRIS PILATUS 300K |
| Wavelength(s) | 0.9789 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 69.655, 82.179, 89.324 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 24.110 - 1.581 |
| R-factor | 0.2007 |
| Rwork | 0.200 |
| R-free | 0.22290 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3gus |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.13_2998) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 50.000 | 1.610 |
| High resolution limit [Å] | 1.580 | 1.580 |
| Rmerge | 0.105 | 0.213 |
| Rmeas | 0.118 | 0.238 |
| Rpim | 0.053 | 0.104 |
| Number of reflections | 70461 | 3455 |
| <I/σ(I)> | 32.61 | |
| Completeness [%] | 99.7 | 99.4 |
| Redundancy | 5.4 | 5.2 |
| CC(1/2) | 0.988 | 0.952 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1M MES PH5.8 ,30% PEG6000 ,10mM DTT |






